当前位置: X-MOL 学术Int. J. Clin. Oncol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Management and outcome of pediatric Wilms tumor with malignant inferior Vena cava thrombus: largest cohort of single-center experience.
International Journal of Clinical Oncology ( IF 3.3 ) Pub Date : 2020-04-05 , DOI: 10.1007/s10147-020-01667-0
Moatasem Elayadi 1, 2 , Mahmoud Hammad 1, 2 , Kareem Sallam 3 , Gehad Ahmed 3, 4 , Soha Ahmed 5, 6 , Ahmed Ibrahim 7 , Amal Refaat 8, 9 , Naglaa Elkinaai 10, 11 , Alaa Younes 4, 12 , Norbert Graf 13 , Wael Zekri 1, 2
Affiliation  

Background

Wilms tumor (WT) with an inferior Vena cava (IVC) malignant thrombus comprises 4–10% of all WT cases.

Methods

This retrospective analysis included 51 pediatric patients presenting at Children Cancer Hospital Egypt-57357 from July 2007 to December 2016 with the diagnosis of WT with malignant IVC thrombus.

Results

Median age at presentation = 4.4 years and 28 cases (55%) were females. Twenty-five patients (49%) were metastatic and 4 patients (7.8%) had bilateral disease. Forty-seven cases (92.2%) had favorable histology with no evidence of anaplasia. Level of thrombus extension at presentation was classified as infra-hepatic, retro-hepatic, supra-hepatic and intra-cardiac in 33, 9, 6 and 3 patients, respectively. Fifty patients started neoadjuvant chemotherapy (CTH) with 16 patients showing complete resolution of thrombus after 6 weeks of CTH. None of the patients developed thrombus progression after neoadjuvant CTH; one patient had stationary intra-cardiac thrombus, while remaining patients showed partial regression of their thrombus and had nephrectomy with en-bloc thrombectomy. The mean cranio-caudal dimension of IVC thrombi at initial presentation was 6.5 cm, and 3.6 cm post 6th week of CTH. The 5-year OS and EFS were 75.9% and 71.1%, respectively. There was no significant correlation of initial levels of thrombus extension with survival.

Conclusion

Neoadjuvant chemotherapy followed by radical nephrectomy with en-bloc thrombectomy and radiotherapy seems a successful approach for management of patients with WT and IVC tumor thrombus. Measurement of the cranio-caudal dimension of thrombus and its response to treatment should be considered in the surgical planning.



中文翻译:

恶性下腔静脉血栓形成的小儿Wilms肿瘤的治疗和结局:单中心经验最大的队列。

背景

下腔静脉(IVC)恶性血栓的Wilms肿瘤(WT)占所有WT病例的4-10%。

方法

这项回顾性分析纳入了2007年7月至2016年12月在埃及儿童癌症医院(England-57357)诊治的WT合并恶性IVC血栓的51例儿科患者。

结果

出现时的中位年龄为4.4岁,其中28例(55%)为女性。二十五例(49%)转移,四例(7.8%)患有双侧疾病。47例(92.2%)的组织学检查良好,没有发育不良的迹象。出现时的血栓扩展水平分别分为33例,9例,6例和3例为肝内,肝后,肝上和心脏内。50名患者开始新辅助化疗(CTH),其中16名患者在CTH治疗6周后血栓完全消失。新辅助CTH后无患者发生血栓进展。1例患者发生了心脏内固定血栓,其余患者表现出部分血栓消退,并进行了全血栓切除术。初次出现时,IVC血栓的平均颅尾尺寸为6。CTH第6周后5厘米和3.6厘米。五年OS和EFS分别为75.9%和71.1%。血栓延伸的初始水平与生存率无显着相关性。

结论

新辅助化学疗法,然后行根治性肾切除术,全血栓切除术和放疗似乎是治疗WT和IVC肿瘤血栓的成功方法。在外科手术计划中应考虑血栓的颅尾尺寸及其对治疗的反应。

更新日期:2020-04-21
down
wechat
bug